

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.24565814 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.19828215 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.02239200 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.91423756 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.69496861 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.44987503 |
| 7 | glutamate secretion (GO:0014047) | 5.37415211 |
| 8 | vocalization behavior (GO:0071625) | 5.33995363 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.30687227 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.20418369 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.17355243 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.09652468 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.87119551 |
| 14 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.85235476 |
| 15 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.80663905 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.77516502 |
| 17 | exploration behavior (GO:0035640) | 4.75419493 |
| 18 | protein localization to synapse (GO:0035418) | 4.72388955 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.67311681 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 4.55710051 |
| 21 | cerebellar granule cell differentiation (GO:0021707) | 4.42617347 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.36800843 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 4.33706292 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.31047225 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.26816411 |
| 26 | dendritic spine morphogenesis (GO:0060997) | 4.12121698 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.09934420 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 4.09741848 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.08909837 |
| 30 | long-term memory (GO:0007616) | 4.08551518 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 4.04834147 |
| 32 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.02262520 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.98419054 |
| 34 | regulation of synaptic plasticity (GO:0048167) | 3.97916137 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.96626385 |
| 36 | positive regulation of membrane potential (GO:0045838) | 3.92148284 |
| 37 | neuron cell-cell adhesion (GO:0007158) | 3.89341528 |
| 38 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.86301002 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.82756964 |
| 40 | long-term synaptic potentiation (GO:0060291) | 3.79955866 |
| 41 | amino acid import (GO:0043090) | 3.79034729 |
| 42 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.78031917 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.75692802 |
| 44 | sodium ion export (GO:0071436) | 3.69299142 |
| 45 | activation of protein kinase A activity (GO:0034199) | 3.68161095 |
| 46 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.68060407 |
| 47 | positive regulation of synapse maturation (GO:0090129) | 3.66573673 |
| 48 | proline transport (GO:0015824) | 3.66439077 |
| 49 | neuromuscular process controlling balance (GO:0050885) | 3.59922758 |
| 50 | synaptic vesicle endocytosis (GO:0048488) | 3.52675038 |
| 51 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.52467438 |
| 52 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.50070984 |
| 53 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.49068743 |
| 54 | gamma-aminobutyric acid transport (GO:0015812) | 3.46476432 |
| 55 | neurotransmitter transport (GO:0006836) | 3.46002854 |
| 56 | behavioral fear response (GO:0001662) | 3.45139883 |
| 57 | behavioral defense response (GO:0002209) | 3.45139883 |
| 58 | regulation of neurotransmitter secretion (GO:0046928) | 3.42367143 |
| 59 | dendritic spine organization (GO:0097061) | 3.41349271 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39885895 |
| 61 | vesicle transport along microtubule (GO:0047496) | 3.38897254 |
| 62 | positive regulation of neurotransmitter transport (GO:0051590) | 3.37050609 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.36171110 |
| 64 | regulation of dendritic spine development (GO:0060998) | 3.34961748 |
| 65 | neuron recognition (GO:0008038) | 3.34665447 |
| 66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.33837997 |
| 67 | response to histamine (GO:0034776) | 3.33347036 |
| 68 | protein localization to endosome (GO:0036010) | 3.30766826 |
| 69 | transmission of nerve impulse (GO:0019226) | 3.28808200 |
| 70 | potassium ion homeostasis (GO:0055075) | 3.26998699 |
| 71 | regulation of neurotransmitter levels (GO:0001505) | 3.24794352 |
| 72 | innervation (GO:0060384) | 3.24418163 |
| 73 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.24368723 |
| 74 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.21808763 |
| 75 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.20836552 |
| 76 | fear response (GO:0042596) | 3.20672724 |
| 77 | chemosensory behavior (GO:0007635) | 3.20586717 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.20411076 |
| 79 | long term synaptic depression (GO:0060292) | 3.20315524 |
| 80 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.20196529 |
| 81 | membrane depolarization (GO:0051899) | 3.20099623 |
| 82 | positive regulation of Rap GTPase activity (GO:0032854) | 3.19875225 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.17579687 |
| 84 | cell communication by electrical coupling (GO:0010644) | 3.16559012 |
| 85 | potassium ion import (GO:0010107) | 3.15758346 |
| 86 | positive regulation of dendritic spine development (GO:0060999) | 3.15138071 |
| 87 | prepulse inhibition (GO:0060134) | 3.13446919 |
| 88 | positive regulation of synaptic transmission (GO:0050806) | 3.12455059 |
| 89 | learning (GO:0007612) | 3.12033984 |
| 90 | regulation of synaptic transmission (GO:0050804) | 3.09388094 |
| 91 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.06950749 |
| 92 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.06340712 |
| 93 | neuromuscular process controlling posture (GO:0050884) | 3.04959642 |
| 94 | axonal fasciculation (GO:0007413) | 3.04696950 |
| 95 | regulation of ARF protein signal transduction (GO:0032012) | 3.03849389 |
| 96 | membrane depolarization during action potential (GO:0086010) | 3.03592077 |
| 97 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.03520628 |
| 98 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.02074227 |
| 99 | auditory behavior (GO:0031223) | 3.02061593 |
| 100 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01084946 |
| 101 | regulation of female receptivity (GO:0045924) | 2.99845507 |
| 102 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.99675652 |
| 103 | synaptic transmission (GO:0007268) | 2.99416446 |
| 104 | response to auditory stimulus (GO:0010996) | 2.99332586 |
| 105 | neuromuscular process (GO:0050905) | 2.98584268 |
| 106 | neuronal ion channel clustering (GO:0045161) | 2.94547166 |
| 107 | membrane hyperpolarization (GO:0060081) | 2.94427421 |
| 108 | regulation of glutamate secretion (GO:0014048) | 2.93794422 |
| 109 | behavioral response to cocaine (GO:0048148) | 2.93738107 |
| 110 | cellular sodium ion homeostasis (GO:0006883) | 2.93242925 |
| 111 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.92681994 |
| 112 | L-amino acid import (GO:0043092) | 2.92349204 |
| 113 | positive regulation of fibroblast migration (GO:0010763) | 2.86913915 |
| 114 | regulation of Rap GTPase activity (GO:0032317) | 2.83427088 |
| 115 | clathrin coat assembly (GO:0048268) | 2.78475851 |
| 116 | cortical actin cytoskeleton organization (GO:0030866) | 2.78007464 |
| 117 | regulation of early endosome to late endosome transport (GO:2000641) | 2.76362529 |
| 118 | signal complex assembly (GO:0007172) | 2.76170369 |
| 119 | regulation of synapse maturation (GO:0090128) | 2.71717287 |
| 120 | cellular response to monoamine stimulus (GO:0071868) | 2.68148199 |
| 121 | cellular response to catecholamine stimulus (GO:0071870) | 2.68148199 |
| 122 | peptidyl-threonine phosphorylation (GO:0018107) | 2.66480440 |
| 123 | regulation of beta-amyloid formation (GO:1902003) | 2.63817055 |
| 124 | cell differentiation in hindbrain (GO:0021533) | 2.62521157 |
| 125 | mating behavior (GO:0007617) | 2.60052893 |
| 126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.58971377 |
| 127 | negative regulation of cell killing (GO:0031342) | 2.58971377 |
| 128 | vesicle docking involved in exocytosis (GO:0006904) | 2.57116989 |
| 129 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.53432967 |
| 130 | peptidyl-threonine modification (GO:0018210) | 2.51370729 |
| 131 | regulation of exocytosis (GO:0017157) | 2.46272669 |
| 132 | cell communication involved in cardiac conduction (GO:0086065) | 2.43617075 |
| 133 | protein targeting to plasma membrane (GO:0072661) | 2.41517124 |
| 134 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.40547700 |
| 135 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.38755607 |
| 136 | positive regulation of protein dephosphorylation (GO:0035307) | 2.37686338 |
| 137 | regulation of ARF GTPase activity (GO:0032312) | 2.37015601 |
| 138 | cortical cytoskeleton organization (GO:0030865) | 2.36694484 |
| 139 | regulation of regulated secretory pathway (GO:1903305) | 2.35020160 |
| 140 | positive regulation of receptor recycling (GO:0001921) | 2.34816321 |
| 141 | vesicle docking (GO:0048278) | 2.33229294 |
| 142 | negative regulation of inclusion body assembly (GO:0090084) | 2.30555340 |
| 143 | neurotransmitter uptake (GO:0001504) | 2.26478435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.10784064 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.42815517 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.35401129 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19936956 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12793732 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11341056 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.09437686 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.02715379 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.80522185 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.79902364 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.79902364 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71518131 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.69098782 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.61644426 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.58827500 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.57991789 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.51923872 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51405787 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49698176 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36369544 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29185743 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27292141 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26331443 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20751611 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20062610 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18355603 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16236542 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.15039603 |
| 29 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.08081927 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.95091380 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94624159 |
| 32 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90384618 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88465410 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88139891 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82326447 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.77587596 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.76917515 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72198264 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70770350 |
| 40 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.69682990 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66259230 |
| 42 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.65275329 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.63492202 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63279897 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62776500 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60352746 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59627095 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57578247 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56433352 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.56171958 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54153892 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52797542 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49524815 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49488590 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46703716 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44173695 |
| 57 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43293677 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42257722 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37692785 |
| 60 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37558189 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35079559 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34093036 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32740473 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32554249 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32365078 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32326013 |
| 67 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31995710 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31991992 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31969401 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31315905 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31289785 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30802144 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29626917 |
| 74 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.29565904 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29018671 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28162375 |
| 77 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28133531 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27598297 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.27247375 |
| 80 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.26582859 |
| 81 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.26502144 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25212728 |
| 83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24164599 |
| 84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23459815 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23349811 |
| 86 | AR_19668381_ChIP-Seq_PC3_Human | 1.21942653 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21300287 |
| 88 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19733945 |
| 89 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19247987 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18741423 |
| 91 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18066919 |
| 92 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.17787201 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17200614 |
| 94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.16998014 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16784064 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15549992 |
| 97 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15133136 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14697940 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13111419 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12221596 |
| 101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.11993728 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11691227 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11334576 |
| 104 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11211019 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11049572 |
| 106 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10566114 |
| 107 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10376874 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10171766 |
| 109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10012808 |
| 110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09003987 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08921122 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08066034 |
| 113 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08028895 |
| 114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07505435 |
| 115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07153590 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06613909 |
| 117 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05283347 |
| 118 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05038385 |
| 119 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03960870 |
| 120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03690657 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02898086 |
| 122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02734845 |
| 123 | MAF_26560356_Chip-Seq_TH1_Human | 1.02255349 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02111035 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01620671 |
| 126 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01387018 |
| 127 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01201612 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00903671 |
| 129 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00751762 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00558210 |
| 131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00531034 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00022497 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99824058 |
| 134 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99817528 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99344156 |
| 136 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97714574 |
| 137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97132904 |
| 138 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96985249 |
| 139 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96904281 |
| 140 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94909463 |
| 141 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94849309 |
| 142 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94543464 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94452408 |
| 144 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93422742 |
| 145 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92836155 |
| 146 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92300975 |
| 147 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92235737 |
| 148 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91462973 |
| 149 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89916439 |
| 150 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89714299 |
| 151 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89071006 |
| 152 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86479983 |
| 153 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86347116 |
| 154 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86252275 |
| 155 | JUN_21703547_ChIP-Seq_K562_Human | 0.85262169 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84768277 |
| 157 | FUS_26573619_Chip-Seq_HEK293_Human | 0.84628198 |
| 158 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84361598 |
| 159 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83925230 |
| 160 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82505532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.59892860 |
| 2 | MP0003880_abnormal_central_pattern | 5.14349493 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.44052674 |
| 4 | MP0004270_analgesia | 3.93681045 |
| 5 | MP0009745_abnormal_behavioral_response | 3.62239188 |
| 6 | * MP0002063_abnormal_learning/memory/cond | 3.59186001 |
| 7 | MP0002822_catalepsy | 3.39160553 |
| 8 | MP0002064_seizures | 3.28530073 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.98173223 |
| 10 | MP0009046_muscle_twitch | 2.90761358 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.89292248 |
| 12 | MP0002272_abnormal_nervous_system | 2.60097854 |
| 13 | MP0001486_abnormal_startle_reflex | 2.55329543 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.45218708 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.43190881 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.35023314 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.34321333 |
| 18 | MP0008260_abnormal_autophagy | 2.32939476 |
| 19 | MP0002736_abnormal_nociception_after | 2.28399382 |
| 20 | MP0003303_peritoneal_inflammation | 2.17298530 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.10272495 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.03269096 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.02400988 |
| 24 | MP0003329_amyloid_beta_deposits | 2.01106649 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.97185695 |
| 26 | MP0008569_lethality_at_weaning | 1.90860455 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.87964743 |
| 28 | MP0001970_abnormal_pain_threshold | 1.86417536 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.85420918 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.84598443 |
| 31 | MP0001348_abnormal_lacrimal_gland | 1.76085467 |
| 32 | MP0004858_abnormal_nervous_system | 1.75481537 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.73110171 |
| 34 | MP0004924_abnormal_behavior | 1.73110171 |
| 35 | MP0003879_abnormal_hair_cell | 1.65028289 |
| 36 | MP0002184_abnormal_innervation | 1.63675806 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.60913451 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.59893250 |
| 39 | * MP0002557_abnormal_social/conspecific_i | 1.56961325 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.56188021 |
| 41 | MP0000778_abnormal_nervous_system | 1.52066072 |
| 42 | MP0003633_abnormal_nervous_system | 1.45490868 |
| 43 | MP0000955_abnormal_spinal_cord | 1.44910086 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.43423271 |
| 45 | * MP0002066_abnormal_motor_capabilities/c | 1.38251756 |
| 46 | MP0003787_abnormal_imprinting | 1.37655675 |
| 47 | MP0001984_abnormal_olfaction | 1.37403045 |
| 48 | MP0005451_abnormal_body_composition | 1.35532887 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.35240348 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.32432116 |
| 51 | MP0004885_abnormal_endolymph | 1.30489288 |
| 52 | MP0003075_altered_response_to | 1.29984738 |
| 53 | MP0001529_abnormal_vocalization | 1.27801537 |
| 54 | MP0003091_abnormal_cell_migration | 1.26978529 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.23801722 |
| 56 | MP0001502_abnormal_circadian_rhythm | 1.23023193 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.21568393 |
| 58 | MP0006276_abnormal_autonomic_nervous | 1.21098569 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.20795623 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.19657085 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.18378220 |
| 62 | MP0003123_paternal_imprinting | 1.18002589 |
| 63 | MP0003631_nervous_system_phenotype | 1.17528062 |
| 64 | MP0003436_decreased_susceptibility_to | 1.13225825 |
| 65 | MP0001851_eye_inflammation | 1.11779595 |
| 66 | MP0001905_abnormal_dopamine_level | 1.09875819 |
| 67 | MP0003828_pulmonary_edema | 1.08858728 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.08458007 |
| 69 | MP0000751_myopathy | 1.08313882 |
| 70 | MP0008874_decreased_physiological_sensi | 1.08059953 |
| 71 | MP0008872_abnormal_physiological_respon | 1.05788133 |
| 72 | MP0004510_myositis | 1.02943177 |
| 73 | MP0002152_abnormal_brain_morphology | 1.02544579 |
| 74 | MP0001188_hyperpigmentation | 0.99383796 |
| 75 | MP0000569_abnormal_digit_pigmentation | 0.99091955 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.98420466 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 0.98075943 |
| 78 | MP0004947_skin_inflammation | 0.97999582 |
| 79 | MP0000604_amyloidosis | 0.97011968 |
| 80 | MP0005058_abnormal_lysosome_morphology | 0.95434525 |
| 81 | MP0003045_fibrosis | 0.95406625 |
| 82 | MP0002069_abnormal_eating/drinking_beha | 0.94771766 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.94051664 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.93776509 |
| 85 | MP0005535_abnormal_body_temperature | 0.93125198 |
| 86 | MP0001177_atelectasis | 0.91602895 |
| 87 | MP0004142_abnormal_muscle_tone | 0.91317523 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.89370594 |
| 89 | MP0001849_ear_inflammation | 0.88546558 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.86010434 |
| 91 | MP0002229_neurodegeneration | 0.85712293 |
| 92 | MP0002133_abnormal_respiratory_system | 0.83184822 |
| 93 | MP0005388_respiratory_system_phenotype | 0.83184822 |
| 94 | MP0004147_increased_porphyrin_level | 0.83165467 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.82001629 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.81197177 |
| 97 | MP0004484_altered_response_of | 0.81074800 |
| 98 | MP0004085_abnormal_heartbeat | 0.80914493 |
| 99 | MP0002090_abnormal_vision | 0.80667248 |
| 100 | MP0003690_abnormal_glial_cell | 0.80625747 |
| 101 | MP0005621_abnormal_cell_physiology | 0.79698055 |
| 102 | MP0003122_maternal_imprinting | 0.76380947 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.75551728 |
| 104 | MP0004215_abnormal_myocardial_fiber | 0.75167799 |
| 105 | MP0002089_abnormal_postnatal_growth/wei | 0.74781234 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.74238800 |
| 107 | MP0003634_abnormal_glial_cell | 0.73183942 |
| 108 | MP0003632_abnormal_nervous_system | 0.72276776 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.72028295 |
| 110 | MP0009278_abnormal_bone_marrow | 0.71924531 |
| 111 | MP0003283_abnormal_digestive_organ | 0.70888274 |
| 112 | MP0000920_abnormal_myelination | 0.70170807 |
| 113 | MP0002419_abnormal_innate_immunity | 0.69959533 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.69118019 |
| 115 | MP0003724_increased_susceptibility_to | 0.68520230 |
| 116 | MP0004233_abnormal_muscle_weight | 0.68485744 |
| 117 | MP0002009_preneoplasia | 0.68299444 |
| 118 | MP0001963_abnormal_hearing_physiology | 0.68060329 |
| 119 | MP0001958_emphysema | 0.67690945 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.66878182 |
| 121 | MP0005409_darkened_coat_color | 0.66867768 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.66862792 |
| 123 | MP0005394_taste/olfaction_phenotype | 0.66258438 |
| 124 | MP0005499_abnormal_olfactory_system | 0.66258438 |
| 125 | MP0000759_abnormal_skeletal_muscle | 0.64514300 |
| 126 | MP0002971_abnormal_brown_adipose | 0.64031684 |
| 127 | MP0004742_abnormal_vestibular_system | 0.62888256 |
| 128 | MP0001664_abnormal_digestion | 0.62213118 |
| 129 | MP0000858_altered_metastatic_potential | 0.61397481 |
| 130 | MP0004808_abnormal_hematopoietic_stem | 0.60501510 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.60478924 |
| 132 | MP0005375_adipose_tissue_phenotype | 0.60297540 |
| 133 | MP0002332_abnormal_exercise_endurance | 0.60144487 |
| 134 | MP0005166_decreased_susceptibility_to | 0.59799101 |
| 135 | MP0003172_abnormal_lysosome_physiology | 0.58363362 |
| 136 | MP0004130_abnormal_muscle_cell | 0.57098183 |
| 137 | MP0001485_abnormal_pinna_reflex | 0.56665685 |
| 138 | MP0000631_abnormal_neuroendocrine_gland | 0.56051649 |
| 139 | MP0002752_abnormal_somatic_nervous | 0.55804701 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.54856911 |
| 141 | MP0005187_abnormal_penis_morphology | 0.52828519 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.52454039 |
| 143 | MP0004043_abnormal_pH_regulation | 0.51858433 |
| 144 | MP0001943_abnormal_respiration | 0.50738733 |
| 145 | MP0000747_muscle_weakness | 0.49225423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.40662218 |
| 2 | Myokymia (HP:0002411) | 7.56718496 |
| 3 | Focal seizures (HP:0007359) | 6.12136329 |
| 4 | Visual hallucinations (HP:0002367) | 5.54979654 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.94242500 |
| 6 | Atonic seizures (HP:0010819) | 4.75304529 |
| 7 | Absence seizures (HP:0002121) | 4.53443399 |
| 8 | Febrile seizures (HP:0002373) | 4.44234131 |
| 9 | Generalized tonic-clonic seizures (HP:0002069) | 4.11437372 |
| 10 | Dialeptic seizures (HP:0011146) | 4.09709569 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 4.09334806 |
| 12 | Action tremor (HP:0002345) | 4.08538940 |
| 13 | Poor eye contact (HP:0000817) | 3.76012307 |
| 14 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.66731805 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.60538799 |
| 16 | Depression (HP:0000716) | 3.55829456 |
| 17 | Broad-based gait (HP:0002136) | 3.53669006 |
| 18 | Papilledema (HP:0001085) | 3.53512180 |
| 19 | Abnormal social behavior (HP:0012433) | 3.37203972 |
| 20 | Impaired social interactions (HP:0000735) | 3.37203972 |
| 21 | Ankle clonus (HP:0011448) | 3.36879670 |
| 22 | Anxiety (HP:0000739) | 3.28391028 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.26878647 |
| 24 | Hyperventilation (HP:0002883) | 3.24756549 |
| 25 | Dysmetria (HP:0001310) | 3.23922785 |
| 26 | Dysdiadochokinesis (HP:0002075) | 3.22240191 |
| 27 | Amblyopia (HP:0000646) | 3.19480993 |
| 28 | Truncal ataxia (HP:0002078) | 3.12755136 |
| 29 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.09577282 |
| 30 | Postural instability (HP:0002172) | 3.07242629 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 3.04161495 |
| 32 | Mutism (HP:0002300) | 2.90112450 |
| 33 | Slow saccadic eye movements (HP:0000514) | 2.88316033 |
| 34 | Urinary urgency (HP:0000012) | 2.85579436 |
| 35 | Impaired smooth pursuit (HP:0007772) | 2.84533347 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.84401510 |
| 37 | Torticollis (HP:0000473) | 2.82377864 |
| 38 | Cerebral inclusion bodies (HP:0100314) | 2.80129179 |
| 39 | Stereotypic behavior (HP:0000733) | 2.78503424 |
| 40 | Annular pancreas (HP:0001734) | 2.78442404 |
| 41 | Focal dystonia (HP:0004373) | 2.70262928 |
| 42 | Tetraplegia (HP:0002445) | 2.65333648 |
| 43 | Drooling (HP:0002307) | 2.62491601 |
| 44 | Excessive salivation (HP:0003781) | 2.62491601 |
| 45 | Scanning speech (HP:0002168) | 2.61462555 |
| 46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.61188338 |
| 47 | Bradykinesia (HP:0002067) | 2.60649348 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.56624367 |
| 49 | Dysmetric saccades (HP:0000641) | 2.55541204 |
| 50 | Intention tremor (HP:0002080) | 2.54918871 |
| 51 | Genetic anticipation (HP:0003743) | 2.51050184 |
| 52 | Epileptiform EEG discharges (HP:0011182) | 2.49303341 |
| 53 | Ventricular fibrillation (HP:0001663) | 2.48757352 |
| 54 | Impaired vibratory sensation (HP:0002495) | 2.45969557 |
| 55 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.43506732 |
| 56 | Diplopia (HP:0000651) | 2.43353990 |
| 57 | Abnormality of binocular vision (HP:0011514) | 2.43353990 |
| 58 | Progressive inability to walk (HP:0002505) | 2.42819886 |
| 59 | Spastic gait (HP:0002064) | 2.42296960 |
| 60 | Insidious onset (HP:0003587) | 2.41780929 |
| 61 | Termporal pattern (HP:0011008) | 2.41780929 |
| 62 | Hemiparesis (HP:0001269) | 2.41175212 |
| 63 | Megalencephaly (HP:0001355) | 2.36504814 |
| 64 | Pointed chin (HP:0000307) | 2.35642028 |
| 65 | Status epilepticus (HP:0002133) | 2.35107145 |
| 66 | Ankyloglossia (HP:0010296) | 2.33921481 |
| 67 | Craniofacial dystonia (HP:0012179) | 2.33859338 |
| 68 | Resting tremor (HP:0002322) | 2.32102696 |
| 69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.30712829 |
| 70 | Absent speech (HP:0001344) | 2.29370037 |
| 71 | Hemiplegia (HP:0002301) | 2.29201998 |
| 72 | Fetal akinesia sequence (HP:0001989) | 2.21727712 |
| 73 | Peripheral hypomyelination (HP:0007182) | 2.16606716 |
| 74 | Generalized myoclonic seizures (HP:0002123) | 2.16425814 |
| 75 | Hypsarrhythmia (HP:0002521) | 2.16016488 |
| 76 | Incomplete penetrance (HP:0003829) | 2.11150325 |
| 77 | Lower limb asymmetry (HP:0100559) | 2.10341857 |
| 78 | Bundle branch block (HP:0011710) | 2.09317922 |
| 79 | Diminished motivation (HP:0000745) | 2.09143893 |
| 80 | Lower limb muscle weakness (HP:0007340) | 2.09032830 |
| 81 | Inability to walk (HP:0002540) | 2.05623847 |
| 82 | Decreased motor nerve conduction velocity (HP:0003431) | 2.02232344 |
| 83 | Delusions (HP:0000746) | 2.01507094 |
| 84 | Rapidly progressive (HP:0003678) | 2.01453307 |
| 85 | Gait ataxia (HP:0002066) | 2.00635557 |
| 86 | Lower limb amyotrophy (HP:0007210) | 1.99577233 |
| 87 | Cerebral aneurysm (HP:0004944) | 1.98142649 |
| 88 | Inappropriate behavior (HP:0000719) | 1.96700689 |
| 89 | Insomnia (HP:0100785) | 1.96694783 |
| 90 | Difficulty running (HP:0009046) | 1.96355659 |
| 91 | Foot dorsiflexor weakness (HP:0009027) | 1.92023978 |
| 92 | Pheochromocytoma (HP:0002666) | 1.90191047 |
| 93 | Apathy (HP:0000741) | 1.89824957 |
| 94 | Amyotrophic lateral sclerosis (HP:0007354) | 1.89644815 |
| 95 | Neuronal loss in central nervous system (HP:0002529) | 1.88594745 |
| 96 | Eczematoid dermatitis (HP:0000976) | 1.86274521 |
| 97 | Bowel incontinence (HP:0002607) | 1.85911244 |
| 98 | Obstructive sleep apnea (HP:0002870) | 1.85531833 |
| 99 | Arterial tortuosity (HP:0005116) | 1.84960917 |
| 100 | Rigidity (HP:0002063) | 1.84157190 |
| 101 | Clonus (HP:0002169) | 1.83581358 |
| 102 | Abnormal EKG (HP:0003115) | 1.80632555 |
| 103 | Psychosis (HP:0000709) | 1.79441067 |
| 104 | Cellulitis (HP:0100658) | 1.78924804 |
| 105 | Abnormality of the periventricular white matter (HP:0002518) | 1.78430528 |
| 106 | Hypercortisolism (HP:0001578) | 1.77723572 |
| 107 | Abnormality of salivation (HP:0100755) | 1.77690454 |
| 108 | Intellectual disability, profound (HP:0002187) | 1.77353599 |
| 109 | Distal lower limb amyotrophy (HP:0008944) | 1.77066415 |
| 110 | Agitation (HP:0000713) | 1.76889437 |
| 111 | Abnormality of the corticospinal tract (HP:0002492) | 1.74836767 |
| 112 | Hyporeflexia of lower limbs (HP:0002600) | 1.74580968 |
| 113 | Blue irides (HP:0000635) | 1.74576150 |
| 114 | Abnormality of oral frenula (HP:0000190) | 1.74422810 |
| 115 | Abnormality of saccadic eye movements (HP:0000570) | 1.74352185 |
| 116 | Spontaneous hematomas (HP:0007420) | 1.73027804 |
| 117 | Hyperacusis (HP:0010780) | 1.72760884 |
| 118 | Deep palmar crease (HP:0006191) | 1.72660533 |
| 119 | Upper limb amyotrophy (HP:0009129) | 1.71527405 |
| 120 | Distal upper limb amyotrophy (HP:0007149) | 1.71527405 |
| 121 | Abnormal large intestine physiology (HP:0012700) | 1.71136085 |
| 122 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70435693 |
| 123 | Abnormality of the foot musculature (HP:0001436) | 1.69125525 |
| 124 | Distal sensory impairment (HP:0002936) | 1.69044572 |
| 125 | Onion bulb formation (HP:0003383) | 1.68805475 |
| 126 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64160163 |
| 127 | Vascular tortuosity (HP:0004948) | 1.63739119 |
| 128 | Spinal canal stenosis (HP:0003416) | 1.62979155 |
| 129 | Akinesia (HP:0002304) | 1.62973759 |
| 130 | Slow progression (HP:0003677) | 1.59350016 |
| 131 | Hammertoe (HP:0001765) | 1.58386835 |
| 132 | Subacute progressive viral hepatitis (HP:0006572) | 1.57844857 |
| 133 | Subaortic stenosis (HP:0001682) | 1.57089087 |
| 134 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.57089087 |
| 135 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.56060731 |
| 136 | Relative macrocephaly (HP:0004482) | 1.55960259 |
| 137 | Mask-like facies (HP:0000298) | 1.55788283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.40573299 |
| 2 | NTRK3 | 4.68040567 |
| 3 | MAP3K9 | 4.07120352 |
| 4 | RIPK4 | 2.95313789 |
| 5 | KSR2 | 2.87250454 |
| 6 | MAP3K4 | 2.76833667 |
| 7 | DAPK2 | 2.68560080 |
| 8 | MINK1 | 2.67463338 |
| 9 | PAK6 | 2.32256686 |
| 10 | PRKD3 | 2.23088328 |
| 11 | MAP2K7 | 2.19193274 |
| 12 | MARK1 | 2.17216191 |
| 13 | CAMKK1 | 2.10758067 |
| 14 | KSR1 | 1.99389157 |
| 15 | MAP3K12 | 1.95651357 |
| 16 | ARAF | 1.87169344 |
| 17 | DAPK1 | 1.86612819 |
| 18 | MAP2K4 | 1.85832326 |
| 19 | MAP3K13 | 1.83104224 |
| 20 | CDK12 | 1.74728491 |
| 21 | NTRK1 | 1.74053332 |
| 22 | TRIB3 | 1.73499437 |
| 23 | NTRK2 | 1.56854673 |
| 24 | MAP3K2 | 1.56406711 |
| 25 | CDK5 | 1.54416452 |
| 26 | PLK2 | 1.42894911 |
| 27 | MAP2K3 | 1.37385944 |
| 28 | CDK19 | 1.37099527 |
| 29 | STK38 | 1.35299829 |
| 30 | RAF1 | 1.34221166 |
| 31 | FES | 1.32590574 |
| 32 | CAMKK2 | 1.25877163 |
| 33 | GRK5 | 1.24383905 |
| 34 | SIK2 | 1.23703776 |
| 35 | WNK1 | 1.23641650 |
| 36 | ICK | 1.21015741 |
| 37 | PRPF4B | 1.19739512 |
| 38 | PRKCG | 1.15866148 |
| 39 | BMPR2 | 1.11536917 |
| 40 | PTK2B | 1.10791596 |
| 41 | TYRO3 | 1.08243241 |
| 42 | TAOK1 | 1.07407387 |
| 43 | TNIK | 1.05708693 |
| 44 | TAOK2 | 1.01158647 |
| 45 | PNCK | 1.00593950 |
| 46 | SMG1 | 0.96120447 |
| 47 | EEF2K | 0.95442500 |
| 48 | CAMK2A | 0.93964470 |
| 49 | MAP3K11 | 0.91196198 |
| 50 | CAMK1 | 0.91022012 |
| 51 | CDK18 | 0.90268844 |
| 52 | RET | 0.88933374 |
| 53 | UHMK1 | 0.88792234 |
| 54 | CDK15 | 0.88452027 |
| 55 | CDK14 | 0.88142985 |
| 56 | JAK1 | 0.86709807 |
| 57 | CASK | 0.86269218 |
| 58 | MAPK13 | 0.83753107 |
| 59 | PDGFRA | 0.82926079 |
| 60 | PDK1 | 0.82477776 |
| 61 | MAP3K1 | 0.82225959 |
| 62 | CAMK2B | 0.81978698 |
| 63 | PINK1 | 0.81451056 |
| 64 | IRAK2 | 0.80573580 |
| 65 | STK11 | 0.80340210 |
| 66 | LATS2 | 0.79609475 |
| 67 | ERN1 | 0.79608306 |
| 68 | PRKCH | 0.78951115 |
| 69 | FGFR3 | 0.77440891 |
| 70 | JAK2 | 0.77172238 |
| 71 | CDK11A | 0.76952935 |
| 72 | PAK3 | 0.75327346 |
| 73 | PDPK1 | 0.73745047 |
| 74 | FGFR4 | 0.71855963 |
| 75 | SGK494 | 0.69959279 |
| 76 | SGK223 | 0.69959279 |
| 77 | ALK | 0.69115978 |
| 78 | NEK1 | 0.68887778 |
| 79 | MAP3K14 | 0.68397684 |
| 80 | SGK1 | 0.67169494 |
| 81 | SCYL2 | 0.63235943 |
| 82 | TTN | 0.61403655 |
| 83 | MAP2K1 | 0.60381119 |
| 84 | SGK2 | 0.59081884 |
| 85 | PHKG2 | 0.58812116 |
| 86 | PHKG1 | 0.58812116 |
| 87 | SGK3 | 0.58675244 |
| 88 | CAMK1D | 0.56441716 |
| 89 | TNK2 | 0.55342282 |
| 90 | LMTK2 | 0.54521549 |
| 91 | MAP3K7 | 0.54347731 |
| 92 | OXSR1 | 0.53891638 |
| 93 | NME1 | 0.53251869 |
| 94 | DYRK1A | 0.52560606 |
| 95 | RIPK1 | 0.51366336 |
| 96 | FGR | 0.50256113 |
| 97 | ZAP70 | 0.49771480 |
| 98 | MARK2 | 0.49584130 |
| 99 | DMPK | 0.49188581 |
| 100 | SYK | 0.48788760 |
| 101 | SIK1 | 0.48762937 |
| 102 | MOS | 0.48264691 |
| 103 | CSK | 0.47724299 |
| 104 | FER | 0.47253750 |
| 105 | BRD4 | 0.45604789 |
| 106 | RPS6KA3 | 0.45530399 |
| 107 | GRK6 | 0.44753059 |
| 108 | HIPK2 | 0.44379941 |
| 109 | PRKCZ | 0.43595638 |
| 110 | FYN | 0.43223599 |
| 111 | DAPK3 | 0.42872084 |
| 112 | PDGFRB | 0.42624114 |
| 113 | BLK | 0.42565808 |
| 114 | MAPK10 | 0.42221872 |
| 115 | ROCK2 | 0.42132405 |
| 116 | YES1 | 0.42018713 |
| 117 | SIK3 | 0.41715526 |
| 118 | MAP3K3 | 0.40262754 |
| 119 | CSNK1G2 | 0.40068472 |
| 120 | BMX | 0.39766521 |
| 121 | CAMK2D | 0.38705213 |
| 122 | BRSK1 | 0.38481133 |
| 123 | CCNB1 | 0.37523268 |
| 124 | CAMK4 | 0.36688568 |
| 125 | BRAF | 0.36427516 |
| 126 | PRKCE | 0.36280868 |
| 127 | CAMK2G | 0.36249273 |
| 128 | CAMK1G | 0.32950952 |
| 129 | MAP3K6 | 0.28163017 |
| 130 | PRKCB | 0.27735526 |
| 131 | NEK6 | 0.27459653 |
| 132 | MAPK12 | 0.26441027 |
| 133 | CDC42BPA | 0.25469374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.46830709 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.09252838 |
| 3 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.85922564 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.83627058 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.74639064 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.60671763 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54633049 |
| 8 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48294715 |
| 9 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.47976685 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.42935438 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30883186 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.26923089 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20767117 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.99906512 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.99269603 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94407814 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.93193185 |
| 18 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.76437730 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.72985967 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71447580 |
| 21 | * Renin secretion_Homo sapiens_hsa04924 | 1.65712254 |
| 22 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.60994105 |
| 23 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58317929 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.58166050 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56645926 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55266400 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52620196 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.36447442 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35077804 |
| 30 | Glioma_Homo sapiens_hsa05214 | 1.32350035 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32085898 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31042747 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29858634 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29530148 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28534466 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21554132 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20404601 |
| 38 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20109943 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19544529 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15352081 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07916310 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.06451341 |
| 43 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05720035 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05645214 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04672820 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04619865 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03361535 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98654599 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97574651 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96659581 |
| 51 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95693651 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93345676 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93254617 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90536499 |
| 55 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.88803001 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87719236 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86539273 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85174780 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84351278 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83821771 |
| 61 | * Axon guidance_Homo sapiens_hsa04360 | 0.83448370 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82815272 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79209795 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78948055 |
| 65 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76919176 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75979037 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74841282 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74576880 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74395147 |
| 70 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73702399 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71608511 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.71225076 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.69916888 |
| 74 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68653815 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68326034 |
| 76 | * Tuberculosis_Homo sapiens_hsa05152 | 0.68277847 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68199131 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67911046 |
| 79 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67654012 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67279139 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67082110 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66150642 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65619585 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65255754 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63152126 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62904568 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62333330 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61947494 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.61643013 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61418875 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.61083285 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60329458 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59107363 |
| 94 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58558982 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58360850 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58017182 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.53588180 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.53161621 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51224225 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50684974 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.50143491 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.50062243 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.50032770 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46868533 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46542527 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44115640 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44087856 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43827956 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43762247 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.43263447 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42892592 |
| 112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42143254 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41804610 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.41630841 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39545597 |
| 116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37487834 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35955934 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.34673180 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30894304 |
| 120 | * Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30033836 |
| 121 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.28783947 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28136680 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.27567919 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27245581 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27158882 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26132348 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25766320 |

